Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Posttransfusion non-A, non-B hepatitis. A prospective study.

R Barcena, E Suarez-Garcia, L A Gil

    Liver
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tracheal deviation due to hematoma after central venous catheter placement.

    Medicina intensiva·2019
    Same author

    Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.

    Journal of viral hepatitis·2016
    Same author

    Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.

    Transplantation proceedings·2016
    Same author

    Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort.

    Journal of viral hepatitis·2016
    Same author

    Energy efficient bead milling of microalgae: Effect of bead size on disintegration and release of proteins and carbohydrates.

    Bioresource technology·2016
    Same author

    Evaluation of the efficacy of therapeutic endoscopy in gastrointestinal bleeding secondary to angiodysplasias.

    Revista de gastroenterologia de Mexico·2016
    Same journal

    Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma.

    Liver·2002
    Same journal

    Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.

    Liver·2002
    Same journal

    Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test.

    Liver·2002
    Same journal

    Macro-aspartate aminotransferase in a female with antibodies to hepatitis C virus.

    Liver·2002
    Same journal

    Cytotoxic response of sinusoidal endothelial cells to polymorphonuclear leukocytes and its potential implication in hypoxia-reoxygenation injury.

    Liver·2002
    Same journal

    Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride.

    Liver·2002
    See all related articles

    Posttransfusion non-A, non-B hepatitis frequently becomes chronic, especially in symptomatic cases. Hepatitis patterns like polyphasic or plateau types increase chronicity risk.

    Area of Science:

    • Hepatology
    • Transfusion Medicine
    • Virology

    Background:

    • Posttransfusion hepatitis remains a significant clinical concern.
    • Non-A, non-B hepatitis accounts for a substantial portion of transfusion-associated liver disease.
    • Understanding the long-term sequelae is crucial for patient management.

    Purpose of the Study:

    • To investigate the clinical features, prognostic factors, and chronic liver outcomes of posttransfusion non-A, non-B hepatitis.
    • To identify predictors of chronicity in patients with posttransfusion hepatitis.
    • To characterize the histological findings in patients with persistent elevated liver enzymes.

    Main Methods:

    • Prospective study of 68 patients with posttransfusion non-A, non-B hepatitis.
    • Clinical data collection including incubation period, symptoms, and jaundice.

    Related Experiment Videos

  • Assessment of chronicity based on elevated alanine aminotransferase (ALT) levels for over 6 months.
  • Analysis of hepatitis patterns (monophasic, polyphasic, plateau).
  • Liver biopsy in 46 patients with persistent ALT elevation.

    • Main Results:

    • The mean incubation period was 5.9 weeks.
    • 67.6% of patients developed chronic hepatitis (elevated ALT > 6 months).
    • Symptomatic hepatitis (95.5% chronicity) and polyphasic/plateau patterns (86.6%-94.4% chronicity) had significantly higher chronicity rates than asymptomatic cases (54.5%) and monophasic patterns (42.5%).
    • Liver biopsies revealed chronic active hepatitis (15 cases), prolonged acute hepatitis (12 cases), and chronic persistent hepatitis (6 cases).

    Conclusions:

    • Posttransfusion non-A, non-B hepatitis has a high rate of chronicity, particularly in symptomatic individuals and those with specific hepatitis patterns.
    • Hepatitis pattern and symptom presence are significant prognostic factors for chronicity.
    • Histological findings indicate a spectrum of chronic liver disease following posttransfusion hepatitis.